Diagnostic performance of GPT-4 in analyzing radiology findings from brain tumors

FHS
October 3, 2024
11:52 am

GPT-4 demonstrates diagnostic capabilities in brain radiology, achieving 73% accuracy for final diagnoses and 94% for differential diagnoses in recent research.

Chinese NMPA approves Innovent-IASO Bio’s myeloma therapy

The US FDA granted orphan drug designation for the CART cell therapy to treat relapsed or refractory multiple myeloma. Credit: www.scientificanimations.com / commons.wikimedia.org. The Chinese

July 3, 2023

FDA approves EpiPen alternative, a nasal spray for anaphylaxis

On Friday, the Food and Drug Administration approved the first needle-free treatment for adults and kids with severe allergic reactions. The approval introduces a competitor

August 9, 2024

Psychedelic Bulletin #146: Numinus Drops Lab, Consolidates Clinics; Study Suggests DMT Safe and Effective Alongside SSRI; Preprint Calls Intracellular Theory of Psychedelic-induced Neuroplasticity Into Question; A Cole Memo for Psychedelics? – Psychedelic Alpha

💸 GlobalData forecasts $7.2bn psychedelic drug market in 2029. The company shared the projection earlier this week, but it looks a little off. For starters, the

September 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.